Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Coronary Disease D003327 70 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Leukemia D007938 74 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Atherosclerosis D050197 85 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Arteriosclerosis D001161 86 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Insulin Resistance D007333 99 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Knapp M Cardioprotective role of sphingosine-1-phosphate. 2011 J. Physiol. Pharmacol. pmid:22314562
Mair N et al. Genetic evidence for involvement of neuronally expressed S1P₁ receptor in nociceptor sensitization and inflammatory pain. 2011 PLoS ONE pmid:21359147
Ishii T et al. The role of sphingosine 1-phosphate in migration of osteoclast precursors; an application of intravital two-photon microscopy. 2011 Mol. Cells pmid:21360199
Antel J and Hohlfeld R Modulation of sphingosine 1-phosphate signaling in neurologic disease. 2011 Neurology pmid:21360856
Hagen N et al. Sphingosine-1-phosphate links glycosphingolipid metabolism to neurodegeneration via a calpain-mediated mechanism. 2011 Cell Death Differ. pmid:21331079
Meng H et al. Loss of sphingosine kinase 1/S1P signaling impairs cell growth and survival of neurons and progenitor cells in the developing sensory ganglia. 2011 PLoS ONE pmid:22096531
Yuan L et al. [The study on protective effect of sphingosine-1-phosphate in cardiomyocytes]. 2011 Zhongguo Ying Yong Sheng Li Xue Za Zhi pmid:22097726
Ling B et al. Sphingosine-1-phosphate: a potential therapeutic agent against human breast cancer. 2011 Invest New Drugs pmid:20041340
Lépine S et al. Autophagy induced by deficiency of sphingosine-1-phosphate phosphohydrolase 1 is switched to apoptosis by calpain-mediated autophagy-related gene 5 (Atg5) cleavage. 2011 J. Biol. Chem. pmid:22052905
Kotani M et al. [Bone and calcium update; bone research update. Trafficking of osteoclast precursors visualized by intravital imaging technology]. 2011 Clin Calcium pmid:22133828
Jiang Z et al. Metabonomic study on women of reproductive age treated with nutritional intervention: screening potential biomarkers related to neural tube defects occurrence. 2011 Biomed. Chromatogr. pmid:20812204
Durafourt BA et al. Differential responses of human microglia and blood-derived myeloid cells to FTY720. 2011 J. Neuroimmunol. pmid:20826007
Fox TE et al. Circulating sphingolipid biomarkers in models of type 1 diabetes. 2011 J. Lipid Res. pmid:21068007
Wang L et al. FTY720-induced human pulmonary endothelial barrier enhancement is mediated by c-Abl. 2011 Eur. Respir. J. pmid:21071472
Siow DL et al. Sphingosine kinase localization in the control of sphingolipid metabolism. 2011 Adv. Enzyme Regul. pmid:21075134
Bieberich E There is more to a lipid than just being a fat: sphingolipid-guided differentiation of oligodendroglial lineage from embryonic stem cells. 2011 Neurochem. Res. pmid:21136155
Kikuta J et al. S1P-targeted therapy for elderly rheumatoid arthritis patients with osteoporosis. 2011 Rheumatol. Int. pmid:21113810
Hu PF et al. Sphingosine-1-phosphate: a potential therapeutic target for rheumatoid arthritis. 2011 Mol. Biol. Rep. pmid:21116853
Xia P and Wadham C Sphingosine 1-phosphate, a key mediator of the cytokine network: juxtacrine signaling. 2011 Cytokine Growth Factor Rev. pmid:21051273
Roviezzo F et al. Sphingosine-1-phosphate modulates vascular permeability and cell recruitment in acute inflammation in vivo. 2011 J. Pharmacol. Exp. Ther. pmid:21421740
Tanfin Z et al. ATP-binding cassette ABCC1 is involved in the release of sphingosine 1-phosphate from rat uterine leiomyoma ELT3 cells and late pregnant rat myometrium. 2011 Cell. Signal. pmid:21803151
Gault CR and Obeid LM Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy. 2011 Crit. Rev. Biochem. Mol. Biol. pmid:21787121
Qadri SM et al. Sphingosine but not sphingosine-1-phosphate stimulates suicidal erythrocyte death. 2011 Cell. Physiol. Biochem. pmid:21865742
Kharel Y et al. Sphingosine kinase type 1 inhibition reveals rapid turnover of circulating sphingosine 1-phosphate. 2011 Biochem. J. pmid:21848514
García-Sáinz JA et al. Mechanisms involved in α1B-adrenoceptor desensitization. 2011 IUBMB Life pmid:21815242
Yang Y and Uhlig S The role of sphingolipids in respiratory disease. 2011 Ther Adv Respir Dis pmid:21900155
Edmonds Y et al. Development of small-molecule inhibitors of sphingosine-1-phosphate signaling. 2011 Pharmacol. Ther. pmid:21906625
Baranowski M and Górski J Heart sphingolipids in health and disease. 2011 Adv. Exp. Med. Biol. pmid:21910081
Hammad SM Blood sphingolipids in homeostasis and pathobiology. 2011 Adv. Exp. Med. Biol. pmid:21910082
Serafimidis I et al. G protein-coupled receptor signaling and sphingosine-1-phosphate play a phylogenetically conserved role in endocrine pancreas morphogenesis. 2011 Mol. Cell. Biol. pmid:21911471
Cuvillier O and Ader I Hypoxia-inducible factors and sphingosine 1-phosphate signaling. 2011 Anticancer Agents Med Chem pmid:21707486
Kim BS et al. The sphingosine-1-phosphate derivative NHOBTD inhibits angiogenesis both in vitro and in vivo. 2011 Biochem. Biophys. Res. Commun. pmid:21888894
Bedia C et al. Regulation of autophagy by sphingolipids. 2011 Anticancer Agents Med Chem pmid:21707487
Weigert A et al. S1P regulation of macrophage functions in the context of cancer. 2011 Anticancer Agents Med Chem pmid:21707489
Watters RJ et al. Targeting sphingosine-1-phosphate receptors in cancer. 2011 Anticancer Agents Med Chem pmid:21707490
Stevenson CE et al. Targeting sphingosine-1-phosphate in hematologic malignancies. 2011 Anticancer Agents Med Chem pmid:21707492
Bourquin F et al. PLP-dependent enzymes as entry and exit gates of sphingolipid metabolism. 2011 Protein Sci. pmid:21710479
Mathew B et al. Role of sphingolipids in murine radiation-induced lung injury: protection by sphingosine 1-phosphate analogs. 2011 FASEB J. pmid:21712494
Olivera A and Rivera J An emerging role for the lipid mediator sphingosine-1-phosphate in mast cell effector function and allergic disease. 2011 Adv. Exp. Med. Biol. pmid:21713655
Vessey DA et al. P2X7 receptor agonists pre- and postcondition the heart against ischemia-reperfusion injury by opening pannexin-1/P2X₇ channels. 2011 Am. J. Physiol. Heart Circ. Physiol. pmid:21685263
Varo-Sánchez GM et al. [Pharmacological targets in multiple sclerosis]. 2011 Rev Neurol pmid:21678322
Alden KP et al. Sphingolipid long chain base phosphates can regulate apoptotic-like programmed cell death in plants. 2011 Biochem. Biophys. Res. Commun. pmid:21683064
Walzer T and Vivier E G-protein-coupled receptors in control of natural killer cell migration. 2011 Trends Immunol. pmid:21664184
Poulsen RR et al. The Sphingosine-1-phospate receptor 1 mediates S1P action during cardiac development. 2011 BMC Dev. Biol. pmid:21668976
Goetzl EJ et al. Defective T cell chemotaxis to sphingosine 1-phosphate and chemokine CCL21 in idiopathic T lymphocytopenia. 2011 J. Clin. Immunol. pmid:21671128
Donati C et al. Sphingosine 1-phosphate induces differentiation of mesoangioblasts towards smooth muscle. A role for GATA6. 2011 PLoS ONE pmid:21629665
Sánchez BA et al. Targeted analysis of sphingoid precursors in human biofluids by solid-phase extraction with in situ derivatization prior to μ-LC-LIF determination. 2011 Anal Bioanal Chem pmid:21394454
Liu X et al. Essential roles of sphingosine 1-phosphate receptor types 1 and 3 in human hepatic stellate cells motility and activation. 2011 J. Cell. Physiol. pmid:21660960
Dickson MA et al. A phase I clinical trial of safingol in combination with cisplatin in advanced solid tumors. 2011 Clin. Cancer Res. pmid:21257722
Kennedy AJ et al. Development of amidine-based sphingosine kinase 1 nanomolar inhibitors and reduction of sphingosine 1-phosphate in human leukemia cells. 2011 J. Med. Chem. pmid:21495716
Brecht K et al. Macrophages programmed by apoptotic cells promote angiogenesis via prostaglandin E2. 2011 FASEB J. pmid:21450910
Benamer N et al. Electrophysiological and functional effects of sphingosine-1-phosphate in mouse ventricular fibroblasts. 2011 Biochem. Biophys. Res. Commun. pmid:21420933
Ocaña-Morgner C et al. Sphingosine 1-phosphate-induced motility and endocytosis of dendritic cells is regulated by SWAP-70 through RhoA. 2011 J. Immunol. pmid:21421853
Kato K et al. Regulation by heat shock protein 27 of osteocalcin synthesis in osteoblasts. 2011 Endocrinology pmid:21427224
López-Juárez A et al. Expression of LPP3 in Bergmann glia is required for proper cerebellar sphingosine-1-phosphate metabolism/signaling and development. 2011 Glia pmid:21319224
Yonamine I et al. Sphingosine kinases and their metabolites modulate endolysosomal trafficking in photoreceptors. 2011 J. Cell Biol. pmid:21321100
Lamana A et al. CD69 modulates sphingosine-1-phosphate-induced migration of skin dendritic cells. 2011 J. Invest. Dermatol. pmid:21412255
Yogi A et al. Sphingosine-1-phosphate-induced inflammation involves receptor tyrosine kinase transactivation in vascular cells: upregulation in hypertension. 2011 Hypertension pmid:21383307
Zhu Q et al. A novel lipid natriuretic factor in the renal medulla: sphingosine-1-phosphate. 2011 Am. J. Physiol. Renal Physiol. pmid:21478479
Takasugi N et al. BACE1 activity is modulated by cell-associated sphingosine-1-phosphate. 2011 J. Neurosci. pmid:21543615
Jackson EK Role of sphingosine-1-phosphate in the renal medulla. 2011 Am. J. Physiol. Renal Physiol. pmid:21511695
Salas A et al. Sphingosine kinase-1 and sphingosine 1-phosphate receptor 2 mediate Bcr-Abl1 stability and drug resistance by modulation of protein phosphatase 2A. 2011 Blood pmid:21527515
Cohen JA and Chun J Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis. 2011 Ann. Neurol. pmid:21520239
Lim KG et al. FTY720 analogues as sphingosine kinase 1 inhibitors: enzyme inhibition kinetics, allosterism, proteasomal degradation, and actin rearrangement in MCF-7 breast cancer cells. 2011 J. Biol. Chem. pmid:21464128
Jung M et al. Anti-ageing effects of a new synthetic sphingolipid (K6EAA-L12) on aged murine skin. 2011 Exp. Dermatol. pmid:21366697
Delogu G et al. Lysophosphatidic acid enhances antimycobacterial response during in vivo primary Mycobacterium tuberculosis infection. 2011 Cell. Immunol. pmid:21703599
Greenspon J et al. Sphingosine-1-phosphate regulates the expression of adherens junction protein E-cadherin and enhances intestinal epithelial cell barrier function. 2011 Dig. Dis. Sci. pmid:20936358
Lan T et al. Simultaneous determination of sphingosine and sphingosine 1-phosphate in biological samples by liquid chromatography-tandem mass spectrometry. 2011 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:21292568
McQuiston T et al. Role of sphingosine-1-phosphate (S1P) and S1P receptor 2 in the phagocytosis of Cryptococcus neoformans by alveolar macrophages. 2011 Microbiology (Reading, Engl.) pmid:21292747
Highkin MK et al. High-throughput screening assay for sphingosine kinase inhibitors in whole blood using RapidFire® mass spectrometry. 2011 J Biomol Screen pmid:21297110
Wu LY et al. Metabolite modulation of HeLa cell response to ENOX2 inhibitors EGCG and phenoxodiol. 2011 Biochim. Biophys. Acta pmid:21571040
Bolli MH et al. Synthetic sphingosine 1-phosphate receptor modulators--opportunities and potential pitfalls. 2011 Curr Top Med Chem pmid:21261590
Hopson KP et al. S1P activates store-operated calcium entry via receptor- and non-receptor-mediated pathways in vascular smooth muscle cells. 2011 Am. J. Physiol., Cell Physiol. pmid:21270296
Ulrych T et al. Release of sphingosine-1-phosphate from human platelets is dependent on thromboxane formation. 2011 J. Thromb. Haemost. pmid:21251196
Catarzi S et al. Redox regulation of ERK1/2 activation induced by sphingosine 1-phosphate in fibroblasts: involvement of NADPH oxidase and platelet-derived growth factor receptor. 2011 Biochim. Biophys. Acta pmid:21256191
Beljanski V et al. Antitumor activity of sphingosine kinase 2 inhibitor ABC294640 and sorafenib in hepatocellular carcinoma xenografts. 2011 Cancer Biol. Ther. pmid:21258214
Doyle T et al. Role for peroxynitrite in sphingosine-1-phosphate-induced hyperalgesia in rats. 2011 Pain pmid:21239112
Bouma HR et al. Low body temperature governs the decline of circulating lymphocytes during hibernation through sphingosine-1-phosphate. 2011 Proc. Natl. Acad. Sci. U.S.A. pmid:21245336
Sassoli C et al. Effects of S1P on skeletal muscle repair/regeneration during eccentric contraction. 2011 J. Cell. Mol. Med. pmid:21199328
Jang S et al. Modulation of sphingosine 1-phosphate and tyrosine hydroxylase in the stress-induced anxiety. 2011 Neurochem. Res. pmid:21076868
Hisano Y et al. The sphingosine 1-phosphate transporter, SPNS2, functions as a transporter of the phosphorylated form of the immunomodulating agent FTY720. 2011 J. Biol. Chem. pmid:21084291
Bäumer W et al. Decreased concentration and enhanced metabolism of sphingosine-1-phosphate in lesional skin of dogs with atopic dermatitis: disturbed sphingosine-1-phosphate homeostasis in atopic dermatitis. 2011 J. Invest. Dermatol. pmid:20811395
Majeed Y et al. Stereo-selective inhibition of transient receptor potential TRPC5 cation channels by neuroactive steroids. 2011 Br. J. Pharmacol. pmid:21108630
Chiba Y et al. Sphingosine-1-phosphate augments agonist-mediated contraction in the bronchial smooth muscles of mice. 2011 Pharmacol Rep pmid:21602610
Doyle T et al. Sphingosine-1-phosphate acting via the S1P₁ receptor is a downstream signaling pathway in ceramide-induced hyperalgesia. 2011 Neurosci. Lett. pmid:21605625
Christoffersen C et al. Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M. 2011 Proc. Natl. Acad. Sci. U.S.A. pmid:21606363
Fenger M et al. Genetics of the ceramide/sphingosine-1-phosphate rheostat in blood pressure regulation and hypertension. 2011 BMC Genet. pmid:21569466
Jongsma M et al. LPA is a chemorepellent for B16 melanoma cells: action through the cAMP-elevating LPA5 receptor. 2011 PLoS ONE pmid:22195035
Lan T et al. Sphingosine kinase-1 pathway mediates high glucose-induced fibronectin expression in glomerular mesangial cells. 2011 Mol. Endocrinol. pmid:21998146
Kang H et al. Fluid shear stress and sphingosine 1-phosphate activate calpain to promote membrane type 1 matrix metalloproteinase (MT1-MMP) membrane translocation and endothelial invasion into three-dimensional collagen matrices. 2011 J. Biol. Chem. pmid:22002053
Gomez L et al. A novel role for mitochondrial sphingosine-1-phosphate produced by sphingosine kinase-2 in PTP-mediated cell survival during cardioprotection. 2011 Basic Res. Cardiol. pmid:22002221
Yester JW et al. Extracellular and intracellular sphingosine-1-phosphate in cancer. 2011 Cancer Metastasis Rev. pmid:22002715
Pyne S et al. Sphingosine kinase inhibitors and cancer: seeking the golden sword of Hercules. 2011 Cancer Res. pmid:21940750
McGuire PG et al. Pericyte-derived sphingosine 1-phosphate induces the expression of adhesion proteins and modulates the retinal endothelial cell barrier. 2011 Arterioscler. Thromb. Vasc. Biol. pmid:21940944
Karuna R et al. Plasma levels of sphingosine-1-phosphate and apolipoprotein M in patients with monogenic disorders of HDL metabolism. 2011 Atherosclerosis pmid:21944699
Arnon TI et al. GRK2-dependent S1PR1 desensitization is required for lymphocytes to overcome their attraction to blood. 2011 Science pmid:21960637
El-Shewy HM et al. Phospholipase C and protein kinase C-β 2 mediate insulin-like growth factor II-dependent sphingosine kinase 1 activation. 2011 Mol. Endocrinol. pmid:22016563
Costello RW et al. Mechanism of sphingosine 1-phosphate- and lysophosphatidic acid-induced up-regulation of adhesion molecules and eosinophil chemoattractant in nerve cells. 2011 Int J Mol Sci pmid:21686182
Sola A et al. Sphingosine-1-phosphate signalling induces the production of Lcn-2 by macrophages to promote kidney regeneration. 2011 J. Pathol. pmid:22025214
Wirrig C et al. Sphingosylphosphorylcholine is a proinflammatory mediator in cerebral arteries. 2011 J. Cereb. Blood Flow Metab. pmid:20551970